Maria Hafez, Assistant Professor at St. Luke’s University Health Network, shared a post by Event Troop on LinkedIn, adding:
“Honored to represent St. Luke’s University Health Network at the Precision Oncology Summit (POSS26).
This work reflects what we stand for at St. Luke’s University Health Network: advancing precision oncology, expanding access to clinical trials, and ensuring innovation meaningfully improves patient outcomes. Bringing this perspective to a global forum reinforces our role as a health system committed not only to excellence, but to impact.
I am grateful to POSS 2026 the invitation and for the honor of being selected to speak for a second consecutive year. Thank you for your continued partnership and for creating a platform that brings global oncology leaders together.
Looking forward to sharing insights and learning alongside colleagues from around the world.”
Quoting Event Troop‘s post:
“What happens in the clinic starts with conversations like these?
At POSS 2026, leaders shaping myeloma care and breast oncology share how research decisions turn into real treatment pathways.
Featuring:
- Prof. Saad Usmani – Chief of Myeloma Service, Memorial Sloan Kettering Cancer Center.
- Dr. Maria Hafez – Director of Breast Cancer Program & Oncology Clinical Trials, St. Luke’s University Health Network.
Focused science. Practical insight. Meaningful impact.
King Salman International Convention Center – Madinah | 12–14 February 2026
Join Us – Free Registration.”
More posts featuring Maria Hafez on OncoDaily.
